Related Experiment Video

Updated: Aug 11, 2026

Electric Cell-substrate Impedance Sensing for the Quantification of Endothelial Proliferation, Barrier Function, and Motility
12:30

Electric Cell-substrate Impedance Sensing for the Quantification of Endothelial Proliferation, Barrier Function, and Motility

Published on: March 28, 2014

Human thrombospondin 2 inhibits proliferation of microvascular endothelial cells

Yasushi Tomii1, Junichiro Kamochi, Hitoshi Yamazaki

  • 1Department of Pathology, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa 259-1193, Japan.

International Journal of Oncology
|January 15, 2002
PubMed

Insights

Human thrombospondin 2 (TSP2) overexpression in colon cancer cells did not affect tumor growth. However, TSP2 secreted by these cells inhibited angiogenesis, suggesting its potential as an anti-cancer therapeutic.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Thrombospondin 2 (TSP2) is recognized as an endogenous inhibitor of angiogenesis.
  • Angiogenesis plays a critical role in tumor growth and metastasis.
  • Understanding TSP2's role in cancer is crucial for developing targeted therapies.

Purpose of the Study:

  • To characterize the functional role of human TSP2 in colon cancer.
  • To investigate the effect of TSP2 overexpression on tumor cell proliferation and angiogenesis.

Main Methods:

  • Human TSP2 cDNA was cloned and transfected into SW-480 colon cancer cells.
  • Stable transfectants overexpressing TSP2 were generated.
  • In vitro and in vivo growth characteristics were assessed.
  • Conditioned media effects on bovine pulmonary microvascular endothelial cell (BPMEC) proliferation were evaluated.

Main Results:

  • TSP2 overexpression did not alter the proliferation of SW-480 colon cancer cells in vitro or in vivo.
  • Conditioned media from TSP2-overexpressing cells significantly inhibited BPMEC proliferation.
  • This suggests TSP2 secreted by cancer cells can inhibit angiogenesis.

Conclusions:

  • Human TSP2 does not directly affect colon cancer cell proliferation.
  • Secreted TSP2 acts as an inhibitor of angiogenesis.
  • TSP2 holds potential as a therapeutic agent targeting tumor angiogenesis.

More Related Videos

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Decellularization and Recellularization Methodology for Human Saphenous Veins11:35

Decellularization and Recellularization Methodology for Human Saphenous Veins

Published on: July 27, 2018

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...